Previous Close | 3.8500 |
Open | 3.8700 |
Bid | 3.9000 x N/A |
Ask | 3.9100 x N/A |
Day's Range | 3.8400 - 3.9400 |
52 Week Range | 3.5800 - 5.9400 |
Volume | |
Avg. Volume | 790,763 |
Market Cap | 938.881M |
Beta (5Y Monthly) | 1.27 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0200 |
Earnings Date | Mar 19, 2024 - Mar 25, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 7.44 |
Subscribe to Yahoo Finance Plus to view Fair Value for WELL.TO
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that the Company will release its Fiscal Fourth Quarter and Year End 2023 financial results for the period ended December 31, 2023, Thursday, March 21, 2024. The Company will hold a conference call and simultaneous webcast to
HEALWELL AI has signed services agreements with both WELL Health USA and U.S. based Circle Medical Technologies Inc., which expands its footprint in the U.S. and will enable U.S. healthcare providers with a suite of artificial intelligence (AI) powered preventative care solutions.HEALWELL’s Pentavere Research Group Inc. has partnered with WELL Health USA’s CRH Medical to access U.S. clinical data to gain insights in supporting patients who are dealing with Inflammatory Bowel Disease and other ga
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce significant growth milestones achieved by its wholly owned subsidiary, OceanMD, along with the introduction of an innovative new product, Health Messenger.